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Abstract
Introduction: In women with macromastia, a type IV skin sparing mastectomy is often required to achieve an
aesthetically pleasing reconstruction. The introduction of “skin-reducing mastectomy”, which inserts a permanent
prosthetic device into a large pouch made by the pectoralis major muscle and an inferior pedicle dermal flap,
allows the surgeon to achieve a safe oncologic result plus a cosmetically satisfying reconstruction.
Objective: We report here our experience with the skin-reducing mastectomy with the aim of emphasizing the
problems associated with the technique.
Materials and method: A study was conduced from April 2009 to November 2012, 74 patients with breast cancer
were selected then received a skin-reducing mastectomy. The enrolled women satisfied the criteria of Nava. Statistical
analysis was conduced to estimate the significance of the outcome results and complication rate.
Result: A total of 88 SRMs were performed and the outcomes were as follows: excellent in 34 patients, good in 21, and
poor in 8. We recorded 25 % of adverse events and statistic helped us to identify patient related factors whose can
increase the complications onset.
Conclusion: Skin-reducing mastectomy is an indispensable procedure to treat cancer in large and pendulous breasts.
The correct patient selection is mandatory to reduce the not negligible complication risk. Skin reducing mastectomy
when is well conduced allow to obtain good results with patient satisfaction but, like other breast-conserving surgeries,
in some case is not the ultimate solution, because it may require some revisions to maintain the optimum results.
To day it be consider relatively safe in selected patient and the gold standard in macormastia immediate
reconstruction.
Keyword: Skin reducing mastectomy, Immediate breast reconstruction, ADM, SRM, Breast implant, Skin sparing
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Introduction
Loosing a breast to cancer has significant negative psycho-
logical and sexual consequences [1], and one aim of pa-
tient care is to ameliorate these problems. Therefore, the
radical mastectomy has become less common and has
been replaced by wide local excision (breast-conserving
therapy) or mastectomy followed by reconstruction [2, 3].
Skin-sparing mastectomy (SSM) was first described in
1991 by Toth et al. [4] as an attempt to maximize skin
preservation in order to provide a more cosmetically
pleasing result after reconstruction. SSM is now consid-
ered an oncologically safe surgical procedure [5–9].
Carlson et al. [10] described 4 types of SSMs, which
were based on the type of incision and the amount of
excised skin. SSM types I to III are intended for small
breasts with a small degree of ptosis, and are carried out
using a periareolar approach. The type IV SSM is
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intended for heavy, pendulous breasts that require large
reduction of the skin envelope plus reduction or masto-
pexy of the contralateral breast [11]. This surgical pro-
cedure has 2 main limitations: the first is the risk for
ischemic necrosis of the two long and thin superior flaps
that close down to the inframammary fold, which may
lead to complications in healing of the inverted T-scar,
such as superficial epidermolysis, wound dehiscence, and
exposure of the implant. The second limitation is exces-
sive upper pole fullness caused by a permanent implant in
the lower pole of the reconstructed breast that lacks pro-
jection [11–13].
To increase the coverage of the lower-pole implant and
reduce the risk of device infection due to wound dehis-
cence or skin necrosis, a technique was developed that
used the skin of the lower breast to create an inferior der-
mal pedicle flap sutured to the inferior border of the pec-
toralis major muscle, thereby creating a musculodermal
pouch for a definitive implant [14]. This procedure was
described by Bostwick and was introduced primarily for
cosmetic surgery and cancer prophylaxis [15]. Hammond
subsequently expanded its use to breast cancer, although
purely for a two-stage reconstruction that used an ex-
pander for the first stage and a definitive implant for the
second stage [16]. In 2006, Nava et al. reviewed this rela-
tively unknown technique naming it as “skin-reducing
mastectomy” [11].
We report herein our experience performing the skin-
reducing mastectomy at the Regina Elena National Cancer
Institute in Rome, Italy, with the aim of emphasizing the
problems associated with the technique.
Materials and methods
Patient selection
This was a retrospective study from April 2009 to
November 2012 of 74 patients selected by our depart-
ment; the local ethics committee approved this study.
Patient data, including age, body mass index (BMI, pa-
tients with BMI > 35 were excluded), smoking status,
and comorbid conditions were recorded. Indications for
surgery, including type of cancer, breast size, and grade
of ptosis were also recorded. The patients were enrolled
in this study based on the criteria of Nava [11], which
included patients with pendulous breasts and an areola-
to inframammary fold distance greater than 8 cm and
suprasternal notch-to-nipple distance greater than 25 cm.
Table 1 summarizes the characteristics of our patients.
None of the study patients had serious comorbidities
that contraindicated surgery or had previously undergone
to breast surgery. Eight patients had diabetes (16.2 %) and
16 patients (21.6) were smokers. All patients who were re-
ferred to our department needing postoperative radiother-
apy due to clinical positivity of axilla were not enrolled to
receive a prosthetic implantation but were scheduled for
autologous tissue reconstruction. All the study patients
fulfilled the oncological indications for undergoing a skin-
sparing mastectomy. Before surgery they consented to the
procedure, the permission to be enrolled in the study, to
take photos and them publication.
Preoperative planning
The midline was marked with the patient in an upright
position. The breast meridian was bilaterally delineated
and the future nipple-areola complex (NAC) was deter-
mined (19–23 cm from the sternal notch). A slightly
modified Wise pattern was then drawn; 2 oblique lines
measuring 7 cm were drawn to form an angle of 30° to
90°, according to the amount of excess skin. The other
ends of the 2 oblique lines were then extended laterally
and medially to join the inframammary fold, as in breast
reduction or mastopexy. The area enclosed in the pattern
below the NAC was designated the dermal flap (colored in
green in Fig. 1).
Table 1 Patient description
Demographic characteristic
Average age (range) 52 years (26 – 67)
Average BMI (range) 27.6 (21 – 34)
Anatomical characteristic
Average breast width (range) 15.8 cm (12 – 17.6)
Average nipple to Inframammary
fold distance (range)
11.7 cm (8 – 17.5)
Average nipple to sterna nock distance (range) 27.9 cm (25 – 36.8) Fig. 1 Preoperative planning
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Surgical procedure
An appropriate areolotome was used to mark the NAC,
which was then excised and stored as a free graft in
physiologic saline solution. A frozen section was taken
for histological examination to determine if there were
malignant cells in the nipple ducts.
A full-thickness skin incision was made along the 2
oblique lateral lines. The epidermis was incised at the
level of the inframammary fold, the area below the NAC
and over the inframammary fold was de-epithelialized,
and a 1-cm-thick dermal flap was created [Fig. 2a]
Mastectomy was then carried out, with dissection along
the subcutaneous plane; Cooper’s ligaments were divided,
so that all breast tissue could be removed and the subder-
mal vascular network could be protected. When indicated,
axillary surgery was performed through the same incision
[Fig. 2b].
The lateral border of the pectoralis major was identi-
fied and elevated to create the pouch. The inferior inser-
tions of the pectoralis major muscle were divided. The
free edge of the pectoralis muscle was then sutured to
the upper edge of the dermal flap, starting medially.
When the suturing was almost completed, an appropri-
ate silicone implant was inserted, followed by comple-
tion of the suturing Fig. 2c-d]. The medial aspect of the
pouch was generally closed using the dermal flap; in pa-
tients where that closure was difficult to perform or
traction deformed the pouch profile, a flap of serratus
muscle was elevated [Fig. 2e] In selected cases, an acel-
lular dermal matrix (ADM) was positioned to increase
the width of the pouch. The skin envelope was then
shaped according to the procedure for aesthetic mam-
moplasty. Care was taken when suturing the skin to re-
duce tension on the wound. The NAC was then grafted
at the appropriate location [Fig. 2f].
Evaluation of postoperative results
All data were collected retrospectively from the operating
theater registers and the surgeons’ logs.
Photographs of the patients were collected before sur-
gery and during follow-up postoperative visits at 2, 6, and
12 months, and used to evaluate the cosmetic results and
to determine the outcomes. The photographs consisted of
frontal side, lateral, and three-quarter side views.
The photographs were assessed for the following pa-
rameters and were graded by 3 external surgeons, and
the mean scores were determined:
– Projection of the lower pole related to the body
(0 = insufficient - breast mount is not appreciable;
1 = moderate - breast lower pole is defined but
without ptosis; 2 = good - lower pole is well
defined and ptosis is appreciable; 3 = optimal -
lower pole and IMF are well defined with an
appropriate ptosis).
– Grade of symmetry (0 = insufficient, 1 = acceptable -
breasts present the “physiologic” asymmetry;
2 = optimal - breasts look quite similar)
– Quality of scar and vitality of NAC (0 = insufficient -
scars are hypertrophic, visible; second intention
healing area are present and the NAC is lost;
1 = acceptable - NAC without projection with
Fig. 2 a Inferior pedicle dermal flap raising; b subcutaneous mastectomy; c Implant positioning; d Prosthesis coverage suturing dermal flap to
inferior border of pectoralis muscle; e Serratus muscle elevation to close the pocket lateral aspect, f Final sutures
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some dyschromic areas, scars are quite hypertrophic
but hided from the breast; 2 = good - Nipple with
light projection, areola well healed scars
normotrophic; 3 = optimal - NAC maintains its
original aspect, scars are less visible)
– Visibility of prosthesis (0 = always; 1 = in some
positions; 2 = never)
The results were estimated from the photographs
and data overlapping using a computer graphic pro-
gram (Anthology - DEKA me.la S.r.l., Calenzano-
Florence. Italy) following our outcome scale and then
classified as excellent, good, or poor, based on the
total score of the parameters (poor = 0–3, good = 4–7,
excellent = 8–10).
Patient satisfaction was determined using the modified
questionnaire from the Michigan Breast Reconstruction
Outcome Scale (Table 2) [2, 17].
Statistical analysis
Complications incidence was analysed to find factors
related to their onset. Aspects surgery relate such us ax-
illary clearance or ADM implantation have been evalu-
ated. Patient factors like smoking status, diabetes, age
and BMI were also studied. The impact of oncologic
therapies was studied as well. The Fisher exact test was
used to compare the frequency of categorical variables.
t-test was used to determine statistical significance for
categorical data.
The correlation between patient satisfaction score and
implant volume was analysed as well. The Pearson cor-
relation test were used to investigate that connection.
Analysis was carried out with SPSS version 22 (IBM
Corporation, USA).
Results
A total of 88 skin-reducing mastectomies were per-
formed (14 patients underwent bilateral procedures).
The minimum duration of follow-up was 12 months
(mean, 18 months), and no local recurrences were noted
but among them 9 have developed systemic disease.
Interpolation of the clinical data with our outcome
scale led to the following results: excellent for 39 pa-
tients (52.7 %), good for 27 (36.5 %), and poor for 8
(10.8 %) [Figs. 3, 4, 5].
Patient satisfaction was as follows: 32 patients (43.3 %)
were highly satisfied (score, 7–16), 34 (45.9 %) were
moderately satisfied (score, 17–25), 8 (10.8 %) were not
satisfied (score, 26–35).
Oncologic therapy
Because of tumor size and histologic features, 8 patients
received neoadjuvant chemotherapy, and 3 months after
therapy underwent to skin reducing mastectomy with
axillary clearance.
There were 27 patients with metastasis-positive of sen-
tinel lymph node detected at surgery, who underwent
axillary lymphadenectomy through the mastectomy sur-
gical incision. These patients received adjuvant chemo-
therapy after their wound had healed [Table 3].
Among them 6 patients had indication to post opera-
tive radiotherapy.
Fourteen patients received bilateral procedures: 3 were
carrier of BRCA mutation and 11 showed bilateral can-
cer (eight woman had had different cancer histology be-
tween the two breasts) 21 prophylactic procedures were
performed: 15 patients received unilateral skin reducing
mastectomy: 11 for previous contralateral tumor and 4
were positive for BRCA genes mutation.
Nipple-areola-complex reconstruction
The NAC was immediately grafted for 82 breasts; 6
NACs were positive for cancer and therefore not used.
There were 53 (64.4 %) breasts with complete attach-
ment of the NAC grafts; 24 nipples (29.5 %) showed loss
of projection, small areas of dyschromia, or small areas
of necrosis; and 5 (6.1 %) breasts (6.1 %) lost the NAC. No
pedicle NAC flap were created to correct breast ptosis.
Each NAC had been routinely repositioned as a free
graft in order to increase the chances for survival. We
achieved a high survival rate. Nineteen nipples showed
dyschromic areas, 5 patients developed total necrosis of
the NAC, and 5 developed partial loss healed by second
intentions.
Nipple reconstruction was performed for 4 patients
using our previously described technique [18] followed
by tattooing the areola, for 4 patients using a tissue graft
from the genitalia, and for 3 patients using a star flap.
Breast implants, ADM patch, and contralateral reshaping
Anatomically shaped silicone gel implants were used
(Allergan, Irvine, CA; Mentor, Berkshire, UK). Charac-
teristics of the prostheses are summarized in Table 4.
Table 2 Parameter used to investigate patients satisfaction
1) Knowing what I know today, I would definitely
choose to have breast reconstruction.
2) Knowing what I know today, I would definitely
choose to have the type of breast reconstruction I had.
3) Overall I Am satisfied with my reconstruction.
4) I would recommend the type of reconstructive
procedure I had to a friend.
5) I felt that I received sufficient information about
my reconstructive options to make an informed choice.
6) The size and shape of my breasts are the same.
7) My reconstructed breast feel soft to the touch.
De Vita et al. Journal of Experimental & Clinical Cancer Research  (2015) 34:120 Page 4 of 11
For 18 procedures, a serratus muscle flap was used to
cover the lateral aspect of the implant. A total of 14
ADM patches were implanted in 10 patients (4 patients
received bilateral ADMs).
Contralateral adjustments were performed for 45
patients as follows: 4 women received superior pedicle
mammoplasty, 16 patients underwent inferior pedicle
reduction mammoplasty, 21 underwent superomedial
pedicle breast reduction, and 4 patients following the
Toreck technique.
Complications
There were 22 adverse events (25 % of SRM), including
some during the early postoperative period (before the
fifteenth postoperative day). The adverse events are
shown in Table 5 and their statistical interpretation is
summarized in Table 6.
There were 7 complications involving the skin envelope
and wound. Superficial epidermolysis near the vertical scar
occurred in 4 patients, and minor wound dehiscence oc-
curred in 3 patients. Four of these complications were
treated conservatively and 3 patients received a surgical
revision. The two patients with exposition of the pros-
thesis underwent removal of the implant. Six months after
implant removal one of these patients underwent a pedi-
cled TRAM flap procedure, which maintains a cutaneous
pad to replace the lost skin mound. The second patient
refused to undergo autologous reconstruction and
6 months after removal received a tissue expander.
Vascular complications developed mainly in patients
who were smokers. There was no statistical difference in
the rate of vascular complications in our patients and the
rates that have been reported in the literature [8–12].
Implant substitution was performed for 19 breasts
(24.5 %), which included 15 performed because of capsu-
lar contracture and 4 because patients requested a bigger
implant. About 12 months after the initial surgery, fat
grafting was performed for 26 patients to improve the
coverage of the upper pole of the implant and skin texture.
Discussion
Skin reducing mastectomy: history and rationale
Several methods for repairing defects after mastectomies
of small breasts have been reported, including autolo-
gous tissue transfer [19–22], one- or two-step prosthetic
implantation [14, 22, 23], or a combination of the au-
tologous flaps and prosthetic implantation. The main
difficulty in performing immediate breast reconstruction
using a subpectoral implant is inadequate space at the
lower and medial portions of the pouch due to the at-
tachments of the pectoralis major muscle to the ribs
[11]. The distal insertions of the muscle are therefore
usually divided, placing the implant in the subcutaneous
plane.
Fig. 3 45 years old woman with huge and pendulous breasts, the cancer was located in the right one. a Before surgery; b 2 months follow-up
De Vita et al. Journal of Experimental & Clinical Cancer Research  (2015) 34:120 Page 5 of 11
In women with macromastia, a type IV SSM is often
required to achieve an aesthetically pleasing reconstruc-
tion. A periareolar approach does not allow an adequate
cutaneous excision, and several Wise pattern excisions
have been developed to solve the problem [2, 21, 24].
However, these procedures have resulted in several compli-
cations that were associated with cutaneous flap skeletoni-
zation and inadequate space for placing an appropriate
permanent implant [25].
The introduction of the Bostwick technique [15], today
known as “skin-reducing mastectomy” [11], which in-
serts a permanent prosthetic device into a large pouch
made by suturing the pectoralis major muscle to the
superior border of an inferior pedicle dermal flap [11],
allows the surgeon to achieve a safe oncologic result plus
a cosmetically satisfying reconstruction. Recentely Querci
della Rovere subsequently reported his experience using a
two-stage procedure [13].
The inferior pedicle dermal flap enables the construc-
tion of a large pouch and acts as a shield between the
prosthesis and the skin wound. We believe that this
shield is a major advantage of this procedure.
The subcutaneous mastectomy is carried out in a
superficial plane immediately under the dermis, and
leads to reduced perfusion of the cutaneous envelope,
resulting in increased numbers of vascular complica-
tions, especially at the T-junction, where wound dehis-
cence has often been observed. The integrity of the
dermal flap prevents direct exposure of the prosthesis to
the external environment, reducing the risk of postoper-
ative contamination [11].
In our opinion, an important advantage of this flap is
its plasticity, which allows complete coverage of the
lower pole of the implant, keeps a well definition of the
inframammary fold and provides a soft cushion for the
implant.
Skin-reducing mastectomy and ADM
In patients needing a very large implant, for which the
dermal and anterior serratus flaps are inadequate, we
use an ADM patch. This biologic material not only pro-
vides initial structural strength and bulk, but also allows
relatively rapid vascular ingrowth and serves as a scaf-
fold for new tissue formation [26, 27].
A total of 14 ADM patches were implanted in 10 pa-
tients (4 patients received bilateral ADMs) and all received
ADMs derived from fetal bovine dermis (SurgiMend PRS,
Vedise Hospital, Italy).
Generally, we reserve the use of an ADM for patients
who have undergone previous breast surgery such as
Fig. 4 43 years old woman with 3th degree of ptosis on the right breast and previous simple mastectomy and expander implantation on the
left. Due the previous multifocal cancer we decided to perform a preventive SRM on the right. a Before surgery; b 12 months follow-up
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quadrantectomy, for patients with extremely high inser-
tions of their pectoralis muscle, and for patients needing
a large breast implant or large pouch. We have placed
these patches on the lateral side of the pouch, thereby
avoiding the need to detach the serratus muscle. There
were only 2 patients for whom we inserted the ADM be-
tween the dermal flap and the free border of the pector-
alis muscle, because the distal portion of the flap was
not found to have an adequate blood supply [Fig. 6].
In 4 breasts an ADM was almost used as a substitute
for the dermal flap, because the tumor was adherent to
the skin. We decided not to remove the entire dermal
flap and cover the lower pole of the breast implant using
an ADM patch, but preferred to leave a 1- to 2-cm flap
to place the ADM at the inframammary fold (IMF). This
small flap was placed under the incision of the IMF, to
prevent exposition of the ADM if wound dehiscence
developed reducing the risk of implants infection.
Fig. 5 42 years old woman with huge and pendulous breasts, the cancer was located in the right one. a Before surgery; b 40 days follow-up
Table 3 Oncological Outcome
Cancer Histology N of cancers Lymph node status
Ductal Cancer 42 cancer (5 patient showed bilateral disease) 35 axillary clearances due to
Lobular Cancer 12 cancer (6 patient showed bilateral disease) 27 sentinel nodes were positive 8 Patients received neoadjuvant
chemotherapy
Cancer stage N of cancers N of nodes cases
Tis 6 1 5
T1 27 1 – 4 24
T2 26 >4 6
T3 8
Prophylactic procedures 14 patients (3 bilateral BRCA; 11 previous
contralateral cancer)
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Skin flap quality is important for surgery using a bio-
logic patch. In reconstructive surgery of the breast, only
the side of the ADM in contact with tissue is useful for
integration; the other side of the ADM is in contact with
the implant. If tissue necrosis develops, the ADM cannot
be integrated, and then both devices require removal at
the very least. No ADMs were used in our study for pa-
tients where there was concern about the condition of
the skin.
There were complications involving 6 breasts receiving
an implant and ADM patch. The most common compli-
cation was a seroma persisting for some weeks after
surgery. Three patients with seroma underwent percu-
taneous drainage and systemic antibiotic therapy. Two
patients showed early vascular failure signs of the skin
envelope and underwent immediate surgical revision to
prevent ADM exposition. One patient developed cellu-
litis of the cutaneous envelope, manifested as swelling
and fever, and she underwent removal of the prosthesis.
To minimize manipulation of the ADM patch, we
rehydrated the device directly in its original container.
After cleaning the surgical field using chlorhexidine, the
surgeon attached the ADM patch to the muscle using
absorbable suture. The important issue for ADM is cor-
rect placement. It is important for preventing the folding
or duplication of the patch, which can increase the risk
of seroma and lead to failure of ADM integration.
To further decrease the risk of seroma in patients re-
ceiving an ADM patch, the drain was left in situ until
the daily amount of aspirate was about 10 to 20 mL (in
patients who did not receive an ADM patch, the drain was
removed when the daily volume of aspirate was 50 mL).
Our complication rate for all patients who received an
ADM implantation (not only those undergoing skin re-
ducing mastectomy) appears to be lower than reported
in other studies [28].
We believe that our lower complication rates are a re-
sult of the narrow indications that we follow for employ-
ing ADM patches and of the meticulous intraoperative
manipulations of ADM patches. To our knowledge, there
are no published similar studies on the complication rate
of ADM patches that can be used for specific comparison
to our results.
Comment to results of statistical analysis
We recorded a statistical correlation among complica-
tion onsets and some patient life style conditions
[Table 6]. BMI and diabetes present the higher level of
significance. Flap thickness seems to be the only surgery
related factor that increases the risk of complication devel-
opment. About the ADM use we didn’t record significa-
tive relation. Nonetheless we observed high percentage of
complication in those patients who received ADM like
seroma formation and long lasting drains but this finding
it’d be dependent to the small number of patients.
Although our series is smaller, we concord with Korwar
study didn’t find a significative correlation of SRM with
postoperative radiotherapy, nevertheless the 6 patient who
received ionizing therapy request more adjuvant proced-
ure to maintain the result such us lipofilling or implant
substitution after capsular contraction [29].
The most important find is highlighted by Pearson
correlation test that showed an atypical not linear rela-
tion [Table 6]. In fact we observed a linear correlation
between satisfaction score and implant volume up to
475 cc then a trend inversion was recorded. We went to
study this phenomenon looking for patients who re-
ceived wider implant and reported lower score. We dis-
cover that they had BMI higher the 31. This finding is
well known in literature where is highly reported obesity
have to be consider as exclusion criteria to implant based
breast reconstruction.
Tips and tricks and some possible variations
During creation of the dermal flap, care must be taken
to preserve the integrity of the inframammary fold to
allow a natural-appearing and physiologic ptosis [30].
We do not agree with Prathap [31], who recommends
suturing the dermal pedicle to the thoracic wall to better
define the inframammary fold, because that procedure
compromises vascularization, leading over time to re-
duction in the volume of the lower pole. We also do not
agree with Hammond [16] and Querci della Rovere [13]
to place an expander, because in patients where survival
of the skin envelope is doubtful or a two-step recon-
struction is scheduled, we prefer to perform a traditional
mastectomy followed by placement of a breast expander
into a muscular pouch.
It is our opinion that skin is placed at risk not when
the prosthesis presence generate high tension on
Table 4 Prosthetic characteristic
Average volume (range) 478.6 g (375–750)
Average High (range) 12.84 cm (11.8 – 15.5)
Average Width (range) 14.64 cm (11.8 – 15)
Average projection (range) 5.97 cm (5.3 – 6.9)







De Vita et al. Journal of Experimental & Clinical Cancer Research  (2015) 34:120 Page 8 of 11
cutaneous surface but when there is vascular damage
after a poorly performed mastectomy, carried out too
much superficial exposing the dermis.
Indeed, for 2 of our study patients who had skin ne-
crosis in the area of the lower pole, the viability of the
dermal flap resulted in second-intention healing.
Regarding patients with an insufficiently large dermal
flap, we do not agree with Colizzi et al., who recommend
increasing the mobility of the flap by detaching the lat-
eral insertion of the flap along the inframammary fold,
because this technique will reduce the vascular support
of the flap [32]. We prefer covering the lateral aspect of
the device, creating a flap using the serratus, which we
performed for 18 study patients.
We would like to emphasize again that it is very im-
portant when creating the flaps to perform a very careful
subcutaneous dissection to preserve the integrity of the
vascular network. Indeed, we prefer to perform the
mastectomy using a blunt scissors to avoid thermal in-
jury to the skin flap caused by electrical devices. We
have found that careful dissection aids in maintaining
the integrity of the dermal and subcutaneous vessels,
thereby increasing the survival rate of dermal flaps.
Conclusions
Nava et al. reported that the skin-reducing mastectomy
allows the surgeon to perform immediate breast recon-
struction and achieve a satisfactory outcome. According
to our outcome scores, we achieved excellent results for
the majority of our patients; however, as for other breast
reconstructions that use prosthetics, surgical revision
may be needed to maintain the results quality.
There were some discordant results for patient satisfac-
tion. Although most of the patients with optimal clinical
results had high scores on the questionnaire from the
Michigan Breast Reconstruction Outcome Scale, indicat-
ing a high degree of satisfaction; some patients, despite
good clinical results, reported low personal satisfaction.
This finding may reflect the extremely high expectations
of some patients who undergo breast reconstruction.
Some of these patients may not understand that a breast
reconstruction is not a cosmetic mammoplasty. We ob-
served this finding more commonly in patients who
underwent to immediate breast reconstruction instead of
a multistage procedure.
The long-term outcomes of skin-reducing mastectomy
have not been clarified. The long-term followup of some
of our study patients has revealed progressive distortion
of the breast profile associated with weight changes of
the patient and/or capsular contracture. We performed
implant substitution for 19 breasts (21.5 %), 15 for capsu-
lar contracture, and 4 patients requested a bigger implant.
Capsular contracture was observed more frequently in
patients with thin dermal flaps or with very large implants.
It is well known that the principal cause of capsular con-
tracture is inadequate coverage of the implant.
Table 6 Results statistical analysis
Complications onset related to P value
( = 0.05)
Graphics representation of correlation between 
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Another important finding was the visibility of the
upper pole of the implant after complete tissue healing.
This has been seen with other SSM procedures. The
upper edge of the implant is often visible because of skin
adhesions to the muscle. To improve coverage of the
upper pole of the implant, fat grafting was performed for
26 patients approximately 12 months after SRM. The
great part of this patient received a full high prosthesis.
In creating the prosthetic pocket, we occasionally ele-
vated a flap of serratus muscle. However, this procedure
is only used in cases of excessive lateral skin flap skeleto-
nization or if the insertions of the pectoralis muscle are
too high.
The use of ADM patches in skin-reducing mastecto-
mies remains controversial, because the risk of, local
complications should be higher than for traditional sur-
gical procedures.
Is it preferable to place a breast implant laterally into
the subcutaneous plane than expose the patient to in-
creased risk of complications? There are many disagree-
ments regarding this question. We think that use of the
ADM patch should be confined to experienced surgeons,
who can provide the expertise to allow this scaffold to
be used safely. Therefore, we prefer to implant a biologic
patch than perform a simple mastectomy. To prevent
exposition of the ADM patch, we have found that it is
important to place the biologic patch at a distance from
surgical incisions. Therefore, if the dermal flap must to
be removed because of oncologic indications, we always
preserve at least 15 to 20 mm of dermal flap in order to
fix the biologic patch above the incision of the inframam-
mary fold. The placement of an ADM between the pector-
alis muscle and dermal flap enables increased projection
of the new breast as well as a wide pouch.
In cases of jeopardize skin we suggest performing an
immediate surgical revision in order to preserve the im-
plants and prevent their exposition and contamination.
We believe that skin-reducing mastectomy with imme-
diate placement of a permanent prosthesis is an indis-
pensable procedure for the treatment of women with
breast cancer in a large and pendulous breast. However,
determining if the patient is suitable for the procedure is
extremely important, because the risks of skin necro-
sis, implant infection, and subsequent removal are not
negligible.
Skin-reducing mastectomies performed by skilled sur-
geons achieve good results and patient satisfaction; how-
ever, as for other breast-conserving surgeries, for some
patients it may not be the ultimate solution, and may re-
quire surgical revision to obtain optimal results.
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